
26/06/2025
Update regarding Primary Care Prescribing:
From 23 June 2025, access to the medication tirzepatide (Mounjaro®) is beginning in England for a small number of patients living with obesity who are at the highest risk of serious health conditions.
In the Black Country, new community-based weight management services are currently being developed to support safe and effective access to this treatment, this means GPs are not yet able to prescribe tirzepatide (Mounjaro®) for weight management in this area.
If you wishes to express disappointment that there is not yet a service in place for the whole of the black country, please direct them to the ICB complaints inbox – bcicb.time2talk@nhs.net
From 23 June 2025, access to the medication tirzepatide (Mounjaro®) is beginning in England for a small number of patients living with obesity who are at the highest risk of serious health conditions.